Connect with us

Hi, what are you looking for?

Editor's Pick

Australia says EU asked it to withdraw vaccine export permit applications

World26 minutes ago (Apr 06, 2021 07:45PM ET)

(C) Reuters. FILE PHOTO: Vial labelled “AstraZeneca coronavirus disease (COVID-19) vaccine” placed on displayed EU flag is seen in this illustration picture

By Colin Packham

CANBERRA (Reuters) – Australia said on Wednesday the European Union asked it to withdraw export permit applications for AstraZeneca (NASDAQ:AZN) PLC’s COVID-19 vaccine, ratcheting up its dispute with Europe over access to pre-purchased inoculations.

The Australian government has blamed the delay of 3.1 million AstraZeneca doses, that were scheduled to be delivered by the end of March, for falling behind in its own vaccination programme.

The European Union on Tuesday denied blocking the shipments of the vaccine to Australia, and said it was not responsible for AstraZeneca’s failure to uphold commitments to other countries.

The dispute underscores massive shortfalls of the AstraZeneca shot across the EU and the impact of any vaccine export curbs on countries that had pre-ordered doses.

“The EC is arguing semantics but at the end of the day, all we want is what Australians have ordered so we can get more vaccines in arms,” the Australian government said in a statement on Wednesday, referring to the EU’s executive branch, the European Commission.

Canberra said the EC requested Australia withdraw export permit applications and that AstraZeneca has told Canberra that it has not been able to secure an export license from Europe to send the pre-purchased doses to Australia.

“The EC has been absolutely clear in their public and private statements that no further doses of (the AstraZeneca vaccine) are to be released until they have had their own orders fulfilled,” Canberra said.

Australia received an initial shipment of 300,000 doses of the AstraZeneca vaccine in late February, which it said was the last received. It has also imported doses of Pfizer Inc (NYSE:PFE)’s vaccine.

The AstraZeneca vaccine arriving from Europe was to underpin the early stages of Australia’s vaccine drive, supplementing 50 million shots of the vaccine that will be produced locally by CSL (OTC:CSLLY) Ltd.

Australia has recorded just 909 COVID-19 deaths since the pandemic began, a small number compared to most nations.

But its inoculation programme is running behind schedule with only about 670,000 people vaccinated against an initial target of 4 million by March-end.

AstraZeneca did not immediately reply to a request for comment on Wednesday.

Australia says EU asked it to withdraw vaccine export permit applications

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.


Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.


Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.


Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Disclaimer: it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved